SCHEMBL24330427

SCHEMBL24330427

c1ccc2c(C3CCN(c4ccc5nc(N6CCOCC6)oc5c4)CC3)c[nH]c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 1/20 0.48
▸ ELANE P08246 1/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ MAPT P10636 1/20 0.43
▸ THRB P10828 1/20 0.43
▸ FGFR1 P11362 2/20 0.43
▸ FLT1 P17948 2/20 0.43
▸ MGLL Q99685 1/20 0.42
▸ BRD4 O60885 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ CREBBP Q92793 1/20 0.41
▸ PRKDC P78527 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ PDGFRB P09619 2/20 0.41
▸ ADRA1D P25100 2/20 0.40
▸ HCRTR1 O43613 1/20 0.40
▸ HCRTR2 O43614 1/20 0.40
▸ KDR P35968 1/20 0.40
▸ GPR119 Q8TDV5 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30611150 0.93 CYP2D6 (0.48) CYP2D6ELANEKDM4EMAPTTHRB
SCHEMBL24331227 0.93 CYP2D6 (0.48) CYP2D6ELANEKDM4EMAPTTHRB
SCHEMBL30611141 0.87 CYP2D6 (0.52) CYP2D6ELANEKDM4EBRD4ALDH1A1
SCHEMBL24331243 0.87 CYP2D6 (0.52) CYP2D6ELANEKDM4EBRD4ALDH1A1
SCHEMBL30611118 0.85 HRH3 (0.49) CYP2D6KDM4EBRD4ALDH1A1POLB
SCHEMBL24330420 0.85 HRH3 (0.49) CYP2D6KDM4EBRD4ALDH1A1POLB
SCHEMBL30611127 0.85 CYP2D6 (0.47) CYP2D6ELANEKDM4EBRD4ALDH1A1
SCHEMBL24331553 0.85 CYP2D6 (0.47) CYP2D6ELANEKDM4EBRD4ALDH1A1
SCHEMBL26912090 0.84 CYP2D6 (0.65) CYP2D6KDM4EMAPTTHRBBRD4
SCHEMBL24330146 0.83 CYP2D6 (0.47) CYP2D6ELANEKDM4EBRD4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230391774-A1 Novel Compounds AC IMMUNE SA (CH) 2023-12-07 — — US claimed
CN-116568684-A Novel compounds AC免疫有限公司 2023-08-08 — — CN claimed
US-20230391774-A1 Novel Compounds AC IMMUNE SA (CH) 2023-12-07 — — US disclosed
CN-116568684-A Novel compounds AC免疫有限公司 2023-08-08 — — CN disclosed
WO-2022078971-A1 NOVEL COMPOUNDS AC IMMUNE SA (CH) 2022-04-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230391774-A1 Novel Compounds MAPT, PSEN2, PSEN1 CYP2D6 4869/4885ELANE 2173/4885KDM4E 4326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback